Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO September 19, 2019
Firefly Health Closes $10.2 Million Series A Funding Round to Expand New Primary Care and Patient Experience Platform September 16, 2019
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy September 16, 2019
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board September 16, 2019